Skip to main content

What the FDA labels say about taking them together

Donepezil/memantine and phenytoin

Donepezil/memantine's FDA label of December 17, 2024 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name donepezil/memantine. The donepezil/memantine label: “Inducers of CYP3A4 could increase the rate of elimination of donepezil.”

Check it at the source: the donepezil/memantine FDA label on DailyMed (effective December 17, 2024, Amneal Pharmaceuticals NY LLC); the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.).

What does the donepezil/memantine label say about phenytoin?

Donepezil/memantine label, drug interactions

Inducers of CYP3A4 (e.g., phenytoin, carbamazepine, dexamethasone, rifampin, and phenobarbital) could increase the rate of elimination of donepezil.

Source: FDA drug label (Memantine and Donepezil Hydrochlorides Extended-release), Amneal Pharmaceuticals NY LLC, effective December 17, 2024 (SPL set 2335950c-be3b-4248-ad04-e9763aee47d2), via openFDA; the full label on DailyMed

What does the phenytoin label say about donepezil/memantine?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name donepezil/memantine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Donepezil/memantine generic labelers
29Phenytoin generic labelers
Donepezil/memantinePhenytoin
Labeled forAlzheimer's diseaseSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)$8.44 per unit 28-10 mg$0.145 per capsule 100 mg capsule
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?